About
VAXICAN develops next-generation immunotherapeutics focusing on prophylactic cancer vaccines using a virus-like particle platform to stimulate the immune system, and provides next-generation genome sequencing services through its Vaxican Genomics division.
Explore VAXICAN's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.